Implementation and Assessment of a Lipoprotein(a) Curriculum for Internal Medicine Residents: A Longitudinal Study
Yehuda Eidensohn, Paul O'Rourke

TL;DR
A short educational session for medical residents increased their confidence and use of Lp(a) testing for heart disease risk.
Contribution
A brief curriculum for residents improved Lp(a) test ordering and confidence, suggesting a practical approach to enhance clinical practice.
Findings
Resident confidence in Lp(a) testing increased significantly after the presentation.
Lp(a) test orders by participants rose from 15% to 44% post-education.
Abstract
Introduction: Lipoprotein(a) (Lp(a)) is an independent risk factor for the development of atherosclerotic cardiovascular disease (ASCVD) and is recognized in guidelines as a risk-enhancing factor favoring the more aggressive management of lipids. However, the clinical utilization of Lp(a) testing has been low, especially among internal medicine providers. Methods: We designed a 30-minute presentation for internal medicine residents that included a general overview of ASCVD risk assessment, differences between Lp(a) and regular low-density lipoprotein cholesterol (LDL-C), and examples of how elevated Lp(a) can change clinical management. Resident confidence in ordering and interpreting Lp(a) was assessed by pre- and post-surveys. Data on Lp(a) ordering practices were abstracted from the electronic medical record for the three months prior to and after the presentation. Results: The…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsLipoproteins and Cardiovascular Health · Health Systems, Economic Evaluations, Quality of Life · Health and Medical Research Impacts
